Constipation in adults

Лазебник, Л. Б.; Туркина, С. В.; Голованова, Е. В.; Ардатская, М. Д.; Остроумова, О Д; Комиссаренко, И. А.; Корочанская, Н. В.; Козлова, И. В.; Успенский, Ю. П.; Фоминых, Ю. А.; Levchenko, S V; Лоранская, И. Д.; Ткаченко, Е. И.; Ситкин, С. И.; Бакулин, И. Г.; Бакулина, Н. В.; Шемеровский, Константин Александрович

doi:10.31146/1682-8658-ecg-175-3-10-33

Cited by 17 publications

(3 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Лечение недостаточности эндокринной функции проводится в соответствии с клиническими рекомендациями Российской ассоциации эндокринологов «Алгоритмы специализированной медицинской помощи больным сахарным диабетом» [164,165,[339][340][341][342][343].…”

Section: панкреатопротекцияunclassified

Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines

Гриневич

Лазебник

Kravchuk

et al. 2023

jour

View full text Add to dashboard Cite

Summary Post- COVID syndrome refers to the long-term consequences of a new coronavirus infection COVID-19, which includes a set of symptoms that develop or persist after COVID-19. Symptoms of gastrointestinal disorders in post- COVID syndrome, due to chronic infl ammation, the consequences of organ damage, prolonged hospitalization, social isolation, and other causes, can be persistent and require a multidisciplinary approach. The presented clinical practice guidelines consider the main preventive and therapeutic and diagnostic approaches to the management of patients with gastroenterological manifestations of postCOVID syndrome. The Guidelines were approved by the 17th National Congress of Internal Medicine and the 25th Congress of Gastroenterological Scientifi c Society of Russia.

show abstract

Section: панкреатопротекцияunclassified

Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines

Гриневич

Лазебник

Kravchuk

et al. 2023

jour

View full text Add to dashboard Cite

show abstract

“…рекомендуется использовать ИПП в двойной дозе и добавлять к терапии висмутсодержащие препараты [14,54]. Согласно данным Hp-EuReg, уровень эрадикации по ITT (англ.…”

Section: участие авторовunclassified

Helicobacter pylori as a risk factor for gastric cancer: the evidence and primary prevention strategy

et al. 2019

View full text Add to dashboard Cite

Russia is a country with a high prevalence of Helicobacter pylori (HP) infection, a high incidence of gastric cancer, and its late diagnosis. HР infection has been recognized as the leading manageable risk factor for gastric cancer. Accurate diagnostic tests must be used to identify and control the effectiveness of HP eradication, and effective schemes must be implemented for HP eradication. The aim of this article was to analyze the latest consensus documents, systematic reviews and meta-analyzes that reflected the role of HP as a risk factor for the development of gastric cancer, as well as measures for the risk reduction. We describe in detail the diagnostic methods for HP infection, provide data on their use in the Russian Federation, and analyze the efficacy of eradication regimens. In all HPinfected individuals, HP leads to chronic inflammation in the gastric mucosa and launches a precancerous cascade (Correa's cascade). The risk of gastric cancer increases with severe atrophy, intestinal metaplasia and dysplasia. Primary prevention of gastric cancer is most effective if the eradication is performed before atrophic gastritis develops. The available consensus documents underline the importance of HP infection identification by accurate diagnostics at this stage of chronic gastritis. In Russia, the primary HP diagnosis is based on histology (37.7%), rapid urease test (29.2%), and serology (29.7%). HP stool antigen test (31.3%), 13C-urea breath test (23.4%) and the histological method (23.3%) are most often used to control eradication. Currently, the first line of eradication therapy is recommended as triple therapy with clarithromycin prescribed for 14 days. It is recommended to use double dose of proton pump inhibitors and bismuth to increase the effectiveness of this scheme. A 14-days triple regimen enhanced by bismuth has been recommended as the first-line therapy in the Russian Federation.

show abstract

“…Следовательно, Римские критерии запора (Рим-IV, 2016) рекомендуют диагностировать почти в 10 раз меньше случаев нерегулярности ритма дефекации, чем будет выявлено этих нарушений при учёте только частоты стула ниже 3 раз/нд. [6,11,33].…”

unclassified

Bradienteria syndrome in the Internal Medicine clinic

Шемеровский

Селиверстов

2022

jour

View full text Add to dashboard Cite

It is known that normal intestinal activity is a fundamental circadian rhythm associated with the sleep — wake cycle, the frequency of which should be at least 7 times a week. Currently, a sufficient number of clinical studies have accumulated, confirming the fact that constipation increases the risk of developing not only diseases of the digestive, but also cardiovascular, endocrine, immune, and other systems of the human body. Early diagnosis and treatment of bradienteria syndrome, as a proven predictor of a number of diseases of the internal organs, contributes to the prevention of their development and progression. It is important that the diagnosis of bradienteria syndrome should be carried out taking into account the presence of three clinical stages, since stages, II and I are 10 times more common than stage III.

show abstract

Constipation in adults

Abstract: .

Cited by 17 publications

References 54 publications

Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines

Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines

Helicobacter pylori as a risk factor for gastric cancer: the evidence and primary prevention strategy

Bradienteria syndrome in the Internal Medicine clinic

Contact Info

Product

Resources

About